Trial Profile
Pharmacokinetic/pharmacodynamic study of the PassPort transdermal insulin delivery system in type 1 diabetes patients.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 09 Jan 2009 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 09 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Aug 2007 New trial record.